Windham Community Memorial Hospital, INC.

Windham Community Memorial Hospital, INC. was paid $69.61M by Medicaid between Jan 2018 and Dec 2024, across 350 billing codes. Its largest line is 99285, emergency room visit (most serious) — 24% of everything it billed.

33Billing provider infoWINDHAM COMMUNITY MEMORIAL HOSPITAL, INC.
WILLIMANTIC, CT 06226

33aNPI1023191467assigned 10/21/2006

33bProvider typeHospitalist Physician

28Total paid$69.61M

24GClaims1,313,514

24DCodes billed350

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Hospitalist Physician providers in Connecticut

Rank by total paid#2 of 19

Median peer was paid$10K

This provider vs. median6,710×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	174,036	$8.43M
2019	180,048	$9.21M
2020	154,067	$7.94M
2021	213,808	$10.97M
2022	207,588	$11.24M
2023	211,531	$11.50M
2024incomplete	172,436	$10.31M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	24%	30,283	25,479	$16.41M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	20%	46,127	39,252	$13.69M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	12%	39,771	35,042	$8.52M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.8%	22,351	18,839	$3.34M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.5%	56,407	16,768	$2.44M
45380	Colonoscopy, flexible; with biopsy, single or multiple	2.7%	2,448	2,313	$1.86M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.4%	8,457	7,470	$1.65M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	2,805	2,628	$1.13M
96361	Intravenous infusion, hydration; each additional hour	1.4%	19,690	15,744	$969K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.4%	14,221	11,981	$949K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.2%	10,805	7,381	$847K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.2%	5,955	5,184	$814K

338 more codes

71046	Radiologic examination, chest; 2 views	1.1%	13,996	$789K
97010		1.1%	23,796	$749K
96375	Therapeutic injection; each additional sequential IV push	1.0%	15,397	$699K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	5,355	$663K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	5,342	$660K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,831	$632K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,361	$623K
71045	Radiologic examination, chest; single view	<1%	10,266	$557K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	743	$537K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	919	$493K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,405	$481K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,297	$466K
70450	Computed tomography, head or brain; without contrast material	<1%	7,735	$456K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	5,119	$417K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,658	$396K
62323		<1%	1,115	$389K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	734	$343K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	3,311	$336K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,947	$318K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,415	$314K
97035		<1%	6,853	$280K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,597	$264K
97161		<1%	5,080	$263K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,852	$254K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,558	$239K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,660	$236K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	10,864	$232K
94060		<1%	1,551	$225K
76830	Ultrasound, transvaginal	<1%	2,193	$222K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,193	$156K
77065	Tomosynthesis, mammo	<1%	1,346	$145K
77066	Tomosynthesis, mammo	<1%	1,161	$135K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	11,667	$132K
76642		<1%	2,077	$129K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,038	$125K
90791	Psychiatric diagnostic evaluation	<1%	3,430	$122K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,227	$115K
93971		<1%	1,750	$113K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	655	$112K
72100		<1%	2,988	$107K
97165		<1%	1,735	$103K
76770		<1%	1,349	$98K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	23,722	$98K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	2,845	$97K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	430	$96K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,663	$94K
76536		<1%	1,304	$94K
99232	Hospital visit by a doctor, follow-up day	<1%	6,255	$92K
99213	Doctor's office visit, returning patient (routine)	<1%	4,440	$89K
93017		<1%	2,212	$86K
97014		<1%	2,118	$80K
97162		<1%	1,408	$73K
76801		<1%	684	$70K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,684	$68K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,268	$64K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,260	$64K
97597		<1%	917	$62K
71250		<1%	1,130	$57K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,537	$52K
73562		<1%	3,436	$51K
99222	Initial hospital care, per day, moderate complexity	<1%	1,402	$50K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	5,617	$47K
86900		<1%	2,992	$44K
73030		<1%	2,859	$44K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,445	$43K
72110		<1%	603	$41K
90837	Psychotherapy session, about an hour	<1%	509	$40K
74018		<1%	1,846	$40K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	348	$38K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,977	$38K
74183		<1%	190	$37K
97012		<1%	840	$37K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	23,781	$37K
0011A		<1%	1,031	$32K
0012A		<1%	914	$31K
73630		<1%	3,086	$31K
73130		<1%	2,504	$31K
99239	Hospital discharge day management, more than 30 minutes	<1%	1,084	$30K
73564		<1%	766	$30K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	257	$30K
73610		<1%	2,763	$29K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	809	$29K
76641		<1%	374	$29K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	97	$27K
73110		<1%	1,908	$25K
73502		<1%	1,856	$25K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	60	$24K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	316	$24K
59025	Fetal non-stress test	<1%	165	$22K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	764	$20K
71271		<1%	198	$17K
73221		<1%	94	$17K
95811		<1%	26	$17K
70496		<1%	143	$16K
86780		<1%	1,435	$16K
72141		<1%	117	$16K
90832	Psychotherapy session, about 30 minutes	<1%	740	$16K
70486		<1%	417	$15K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	50,618	$14K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,573	$14K
97116		<1%	1,802	$13K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	10,072	$12K
72040		<1%	314	$12K
0002A		<1%	362	$12K
0001A		<1%	370	$12K
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	297	$11K
99223	Prolong inpt eval add15 m	<1%	226	$9K
73140		<1%	883	$9K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	393	$9K
74220		<1%	78	$8K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	841	$8K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	19,943	$8K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	77	$7K
97535	Self-care/home management training, each 15 minutes	<1%	474	$7K
99203	Doctor's office visit, new patient (routine)	<1%	153	$7K
99205	Prolong outpt/office vis	<1%	111	$6K
0064A		<1%	160	$6K
90834	Psychotherapy session, about 45 minutes	<1%	148	$6K
72070		<1%	155	$6K
93970		<1%	47	$6K
72050		<1%	68	$5K
73700		<1%	97	$5K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	262	$5K
99236	Prolong inpt eval add15 m	<1%	51	$5K
99238	Hospital discharge day management, 30 minutes or less	<1%	301	$5K
36415	Collection of venous blood by venipuncture	<1%	17,122	$4K
10060		<1%	27	$4K
0004A		<1%	119	$4K
96367		<1%	169	$4K
94726		<1%	1,253	$4K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	259	$4K
73080		<1%	467	$4K
93225		<1%	85	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	201	$3K
99204	Doctor's office visit, new patient (more involved)	<1%	111	$3K
G0378	Hospital observation service, per hour	<1%	7,260	$3K
76981		<1%	86	$3K
81025		<1%	15,039	$3K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	27	$3K
90686		<1%	279	$3K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	40	$3K
70491		<1%	27	$3K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,534	$3K
77080		<1%	29	$3K
84702		<1%	1,392	$3K
80053	Comprehensive metabolic panel	<1%	25,394	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	97	$3K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	10,112	$3K
76970		<1%	36	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,511	$3K
96417		<1%	59	$2K
86803		<1%	612	$2K
94618		<1%	161	$2K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	314	$2K
94660		<1%	71	$2K
36430		<1%	13	$2K
93296		<1%	132	$2K
73590		<1%	264	$2K
84703		<1%	2,655	$2K
87340		<1%	621	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	2,361	$2K
87077		<1%	3,823	$2K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	132	$2K
87081		<1%	4,364	$2K
80048	Basic metabolic panel (calcium, ionized)	<1%	20,938	$2K
85027		<1%	1,071	$1K
87070		<1%	2,049	$1K
93270		<1%	62	$1K
97166		<1%	18	$1K
95806		<1%	12	$1K
96415		<1%	19	$1K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	496	$1K
76000		<1%	15	$984.52
90674		<1%	49	$913.90
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,177	$870.34
0031A		<1%	27	$840.00
87205		<1%	1,987	$805.20
0054A		<1%	22	$760.00
72131		<1%	48	$719.24
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	136	$718.50
97032		<1%	22	$715.27
71101		<1%	149	$692.58
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,569	$662.67
87186		<1%	2,267	$654.68
99219		<1%	38	$628.91
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	13	$617.00
83036	Hemoglobin; glycosylated (A1C)	<1%	784	$585.48
72170		<1%	13	$581.41
81003		<1%	23,522	$548.03
88142		<1%	77	$518.04
76870		<1%	13	$494.80
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	176	$486.29
12001		<1%	396	$399.14
85610		<1%	7,970	$373.08
93880		<1%	12	$350.13
83880		<1%	3,468	$298.46
90715		<1%	2,474	$283.82
86850		<1%	2,787	$270.68
80076		<1%	8,311	$269.04
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	292	$263.09
83735		<1%	8,386	$254.63
J3490	Unclassified drugs	<1%	170,307	$250.96
86318		<1%	64	$247.20
84484		<1%	14,654	$234.78
80061	Lipid panel	<1%	41	$217.43
83690		<1%	16,161	$204.16
85379		<1%	3,301	$202.00
70498		<1%	96	$194.21
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,453	$164.06
82105		<1%	13	$160.20
90734		<1%	16	$143.43
82962		<1%	17,989	$132.42
86901		<1%	2,993	$126.52
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,652	$115.64
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	835	$90.00
82803		<1%	1,381	$83.38
87040		<1%	6,300	$73.83
73090		<1%	54	$67.07
82950		<1%	14	$63.56
85652		<1%	1,218	$63.54
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	897	$61.90
86618		<1%	1,819	$48.60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	17	$45.30
82270		<1%	30	$43.54
83605		<1%	4,760	$39.90
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,472	$38.29
85730		<1%	196	$34.38
87015		<1%	481	$31.61
86140		<1%	1,121	$29.27
J7030	Infusion, normal saline solution , 1000 cc	<1%	28,814	$22.72
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,675	$22.32
82550		<1%	4,118	$18.92
86666		<1%	451	$18.56
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	20	$16.79
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	15,151	$15.50
J2785	Injection, regadenoson, 0.1 mg	<1%	983	$13.60
87207		<1%	563	$13.33
96376		<1%	3,329	$12.99
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	45	$12.60
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	15,032	$12.31
87400		<1%	3,526	$11.45
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	10,277	$10.31
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,444	$8.31
82010		<1%	649	$7.21
84132		<1%	831	$4.76
86308		<1%	77	$4.57
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	492	$4.31
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	12,462	$4.13
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,394	$4.09
J1630	Injection, haloperidol, up to 5 mg	<1%	851	$3.60
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,957	$2.41
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	370	$2.13
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	365	$2.10
G0008	Administration of influenza virus vaccine	<1%	156	$2.00
J2060	Injection, lorazepam, 2 mg	<1%	3,005	$1.74
J8540	Dexamethasone, oral, 0.25 mg	<1%	570	$1.34
J1790	Injection, droperidol, up to 5 mg	<1%	906	$1.33
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,495	$1.00
J1836	Injection, metronidazole, 10 mg	<1%	56	$1.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	2,329	$1.00
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,818	$0.94
J7050	Infusion, normal saline solution, 250 cc	<1%	3,264	$0.31
J2550	Injection, promethazine hcl, up to 50 mg	<1%	755	$0.17
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	28	$0.17
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	27	$0.16
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	3,954	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	1,618	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	2,604	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	2,242	$0.00
J2704	Injection, propofol, 10 mg	0%	8,882	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	588	$0.00
J1815	Injection, insulin, per 5 units	0%	1,965	$0.00
91305		0%	22	$0.00
91301		0%	1,827	$0.00
82077		0%	614	$0.00
87807		0%	497	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	38	$0.00
87468		0%	154	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	4,027	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	32	$0.00
12002		0%	83	$0.00
86762		0%	31	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	195	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	59	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	82	$0.00
C1767	Generator, neurostimulator (implantable), non-rechargeable	0%	17	$0.00
86617		0%	47	$0.00
87484		0%	154	$0.00
A6022	Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each	0%	262	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	244	$0.00
88304		0%	12	$0.00
87808		0%	42	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	24	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	165	$0.00
96368		0%	18	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	36	$0.00
91303		0%	26	$0.00
0352U		0%	36	$0.00
90839		0%	97	$0.00
91306		0%	159	$0.00
A4217	Sterile water/saline, 500 ml	0%	73	$0.00
87184		0%	14	$0.00
88342		0%	12	$0.00
A4648	Tissue marker, implantable, any type, each	0%	16	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	26	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	14	$0.00
88312		0%	2,008	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	1,705	$0.00
94729		0%	1,305	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	1,752	$0.00
91300		0%	861	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	1,928	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	569	$0.00
84295		0%	691	$0.00
80143		0%	81	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	125	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	659	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	675	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	2,936	$0.00
29125		0%	124	$0.00
84145		0%	122	$0.00
J7120	Ringers lactate infusion, up to 1000 cc	0%	9,262	$0.00
J7510	Prednisolone oral, per 5 mg	0%	298	$0.00
12011		0%	66	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	360	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	195	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	103	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	168	$0.00
80164		0%	28	$0.00
80179		0%	65	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	12	$0.00
82140		0%	12	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	101	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	65	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	30	$0.00
87469		0%	19	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	15	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMACKIE, JANICE (VP OF FINANCE)